Cargando…

Is recurrence possible in coronavirus disease 2019 (COVID-19)? Case series and systematic review of literature

Can a patient diagnosed with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) be infected again? This question is still unsolved. We tried to analyze local and literature cases with a positive respiratory swab after recovery. We collected data from symptomatic patients diagnosed with SAR...

Descripción completa

Detalles Bibliográficos
Autores principales: Gidari, Anna, Nofri, Marco, Saccarelli, Luca, Bastianelli, Sabrina, Sabbatini, Samuele, Bozza, Silvia, Camilloni, Barbara, Fusco-Moffa, Igino, Monari, Claudia, De Robertis, Edoardo, Mencacci, Antonella, Francisci, Daniela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547550/
https://www.ncbi.nlm.nih.gov/pubmed/33037944
http://dx.doi.org/10.1007/s10096-020-04057-6
_version_ 1783592443297398784
author Gidari, Anna
Nofri, Marco
Saccarelli, Luca
Bastianelli, Sabrina
Sabbatini, Samuele
Bozza, Silvia
Camilloni, Barbara
Fusco-Moffa, Igino
Monari, Claudia
De Robertis, Edoardo
Mencacci, Antonella
Francisci, Daniela
author_facet Gidari, Anna
Nofri, Marco
Saccarelli, Luca
Bastianelli, Sabrina
Sabbatini, Samuele
Bozza, Silvia
Camilloni, Barbara
Fusco-Moffa, Igino
Monari, Claudia
De Robertis, Edoardo
Mencacci, Antonella
Francisci, Daniela
author_sort Gidari, Anna
collection PubMed
description Can a patient diagnosed with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) be infected again? This question is still unsolved. We tried to analyze local and literature cases with a positive respiratory swab after recovery. We collected data from symptomatic patients diagnosed with SARS-CoV-2 infection in the Italian Umbria Region that, after recovery, were again positive for SARS-CoV-2 in respiratory tract specimens. Samples were also assessed for infectivity in vitro. A systematic review of similar cases reported in the literature was performed. The study population was composed of 9 patients during a 4-month study period. Among the new positive samples, six were inoculated in Vero-E6 cells and showed no growth and negative molecular test in culture supernatants. All patients were positive for IgG against SARS-CoV-2 nucleoprotein and/or S protein. Conducting a review of the literature, 1350 similar cases have been found. The presumptive reactivation occurred in 34.5 days on average (standard deviation, SD, 18.7 days) after COVID-19 onset, when the 5.6% of patients presented fever and the 27.6% symptoms. The outcome was favorable in 96.7% of patients, while the 1.1% of them were still hospitalized at the time of data collection and the 2.1% died. Several hypotheses have been formulated to explain new positive respiratory samples after confirmed negativity. According to this study, the phenomenon seems to be due to the prolonged detection of SARS-CoV-2 RNA traces in respiratory samples of recovered patients. The failure of the virus to replicate in vitro suggests its inability to replicate in vivo.
format Online
Article
Text
id pubmed-7547550
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-75475502020-10-14 Is recurrence possible in coronavirus disease 2019 (COVID-19)? Case series and systematic review of literature Gidari, Anna Nofri, Marco Saccarelli, Luca Bastianelli, Sabrina Sabbatini, Samuele Bozza, Silvia Camilloni, Barbara Fusco-Moffa, Igino Monari, Claudia De Robertis, Edoardo Mencacci, Antonella Francisci, Daniela Eur J Clin Microbiol Infect Dis Review Can a patient diagnosed with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) be infected again? This question is still unsolved. We tried to analyze local and literature cases with a positive respiratory swab after recovery. We collected data from symptomatic patients diagnosed with SARS-CoV-2 infection in the Italian Umbria Region that, after recovery, were again positive for SARS-CoV-2 in respiratory tract specimens. Samples were also assessed for infectivity in vitro. A systematic review of similar cases reported in the literature was performed. The study population was composed of 9 patients during a 4-month study period. Among the new positive samples, six were inoculated in Vero-E6 cells and showed no growth and negative molecular test in culture supernatants. All patients were positive for IgG against SARS-CoV-2 nucleoprotein and/or S protein. Conducting a review of the literature, 1350 similar cases have been found. The presumptive reactivation occurred in 34.5 days on average (standard deviation, SD, 18.7 days) after COVID-19 onset, when the 5.6% of patients presented fever and the 27.6% symptoms. The outcome was favorable in 96.7% of patients, while the 1.1% of them were still hospitalized at the time of data collection and the 2.1% died. Several hypotheses have been formulated to explain new positive respiratory samples after confirmed negativity. According to this study, the phenomenon seems to be due to the prolonged detection of SARS-CoV-2 RNA traces in respiratory samples of recovered patients. The failure of the virus to replicate in vitro suggests its inability to replicate in vivo. Springer Berlin Heidelberg 2020-10-10 2021 /pmc/articles/PMC7547550/ /pubmed/33037944 http://dx.doi.org/10.1007/s10096-020-04057-6 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Review
Gidari, Anna
Nofri, Marco
Saccarelli, Luca
Bastianelli, Sabrina
Sabbatini, Samuele
Bozza, Silvia
Camilloni, Barbara
Fusco-Moffa, Igino
Monari, Claudia
De Robertis, Edoardo
Mencacci, Antonella
Francisci, Daniela
Is recurrence possible in coronavirus disease 2019 (COVID-19)? Case series and systematic review of literature
title Is recurrence possible in coronavirus disease 2019 (COVID-19)? Case series and systematic review of literature
title_full Is recurrence possible in coronavirus disease 2019 (COVID-19)? Case series and systematic review of literature
title_fullStr Is recurrence possible in coronavirus disease 2019 (COVID-19)? Case series and systematic review of literature
title_full_unstemmed Is recurrence possible in coronavirus disease 2019 (COVID-19)? Case series and systematic review of literature
title_short Is recurrence possible in coronavirus disease 2019 (COVID-19)? Case series and systematic review of literature
title_sort is recurrence possible in coronavirus disease 2019 (covid-19)? case series and systematic review of literature
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547550/
https://www.ncbi.nlm.nih.gov/pubmed/33037944
http://dx.doi.org/10.1007/s10096-020-04057-6
work_keys_str_mv AT gidarianna isrecurrencepossibleincoronavirusdisease2019covid19caseseriesandsystematicreviewofliterature
AT nofrimarco isrecurrencepossibleincoronavirusdisease2019covid19caseseriesandsystematicreviewofliterature
AT saccarelliluca isrecurrencepossibleincoronavirusdisease2019covid19caseseriesandsystematicreviewofliterature
AT bastianellisabrina isrecurrencepossibleincoronavirusdisease2019covid19caseseriesandsystematicreviewofliterature
AT sabbatinisamuele isrecurrencepossibleincoronavirusdisease2019covid19caseseriesandsystematicreviewofliterature
AT bozzasilvia isrecurrencepossibleincoronavirusdisease2019covid19caseseriesandsystematicreviewofliterature
AT camillonibarbara isrecurrencepossibleincoronavirusdisease2019covid19caseseriesandsystematicreviewofliterature
AT fuscomoffaigino isrecurrencepossibleincoronavirusdisease2019covid19caseseriesandsystematicreviewofliterature
AT monariclaudia isrecurrencepossibleincoronavirusdisease2019covid19caseseriesandsystematicreviewofliterature
AT derobertisedoardo isrecurrencepossibleincoronavirusdisease2019covid19caseseriesandsystematicreviewofliterature
AT mencacciantonella isrecurrencepossibleincoronavirusdisease2019covid19caseseriesandsystematicreviewofliterature
AT franciscidaniela isrecurrencepossibleincoronavirusdisease2019covid19caseseriesandsystematicreviewofliterature